Currently out of the existing stock ratings of Sam Eiber, 9 are a BUY (100%).

Sam Eiber

Work Performance Price Targets & Ratings Chart

Analyst Sam Eiber, currently employed at BTIG, carries an average stock price target met ratio of 50% that have a potential upside of 16.47% achieved within 74 days.

Sam Eiber’s has documented 18 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on EOLS, Evolus at 04-Mar-2026.

Wall Street Analyst Sam Eiber

Analyst best performing recommendations are on ESTA (ESTABLISHMENT LABS HOLDINGS).
The best stock recommendation documented was for ESTA (ESTABLISHMENT LABS HOLDINGS) at 11/5/2025. The price target of $70 was fulfilled within 29 days with a profit of $9.49 (15.68%) receiving and performance score of 5.41.

Average potential price target upside

EOLS Evolus ESTA Establishment Labs Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Apr-2025

$13

$7.16 (122.60%)

$13

5 months 1 days ago
(04-Mar-2026)

0/5 (0%)

$7.41 (132.56%)

Buy Since 14-Feb-2019

$13

$7.16 (122.60%)

$20

6 months 2 days ago
(03-Feb-2026)

4/26 (15.38%)

$8.3 (176.60%)

614

Buy Since 29-Jan-2019

$17

$11.16 (191.10%)

$25

6 months 23 days ago
(13-Jan-2026)

1/15 (6.67%)

$11.28 (197.20%)

10

Hold Since 24-Dec-2025

$22

7 months 12 days ago
(24-Dec-2025)

0/13 (0%)

$15.63 (245.37%)

Buy Since 07-Jun-2023

$19

$13.16 (225.34%)

8 months 3 days ago
(02-Dec-2025)

0/2 (0%)

$12.48 (191.41%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Sam Eiber is most bullish on?

Potential upside of $7.16 has been obtained for EOLS (EVOLUS)

What Year was the first public recommendation made by Sam Eiber?

On 2025

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?